# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-25-024980
Filing Date
2025-11-25
Accepted
2025-11-25 16:05:04
Documents
6
Period of Report
2025-11-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-k.htm | 6-K | 18058
2 | EX-99.1 | ex99-1.htm | EX-99.1 | 77352
3 | EX-99.2 | ex99-2.htm | EX-99.2 | 2096
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 3140
5 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 263790
6 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 312187
| Complete submission text file | 0001493152-25-024980.txt |  | 896537

Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Filer) CIK: 0001857030 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40614 | Film No.: 251521013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)